Any focus on the cost of treatment is incredibly misguided when it comes to personalised medicines because it belies the reality of what they will provide - governments will be paying for less failure and the potential for cures will mean patients will be treated with fewer therapies.
What happens when the government is paying for less failure?
August 7, 2019 Latest NewsNews of the Day
Latest Video
New Stories
-
Final days to help build Australia’s longest running life sciences benchmark survey
July 15, 2025 - - Latest News -
New Australian collaboration to build gene and cell therapy production
July 15, 2025 - - Latest News -
The need to correct a profound misconception of what ethical decision-making is and is not
July 15, 2025 - - Latest News -
Patient Voice Initiative announces the appointment of new president
July 15, 2025 - - Latest News -
HTA reform is fine, but why is the underpinning framework immutable?
July 15, 2025 - - Latest News -
Olympian joins call urging vigilance on meningococcal risk
July 15, 2025 - - Latest News -
Amplia Therapeutics announces additional confirmed partial response in ACCENT trial
July 14, 2025 - - Australian Biotech